Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Genetic heterogeneity in multiple myeloma.

F Magrangeas1, L Lodé, S Wuilleme

  • 1Hematology Laboratory, University Hospital, Nantes, France.

Leukemia
|November 13, 2004
PubMed
Summary

Recent advances in multiple myeloma genetics have identified key abnormalities using molecular cytogenetics. These findings offer prognostic markers and therapeutic targets for improved patient treatment.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Prevention and management of adverse events of Novel agents in multiple myeloma: A consensus of the european myeloma network.

Leukemia·2017
Same author

Biological and prognostic impact of APOBEC-induced mutations in the spectrum of plasma cell dyscrasias and multiple myeloma cell lines.

Leukemia·2017
Same author

Expressed fusion gene landscape and its impact in multiple myeloma.

Nature communications·2017
Same author

Heavy+light chain monitoring correlates with clinical outcome in multiple myeloma patients.

Leukemia·2017
Same author

Nucleotide excision repair is a potential therapeutic target in multiple myeloma.

Leukemia·2017
Same author

Multiple myeloma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up.

Annals of oncology : official journal of the European Society for Medical Oncology·2017

Area of Science:

  • Genetics
  • Oncology
  • Molecular Biology

Background:

  • Significant progress in understanding multiple myeloma genetics over the last decade.
  • Identification of recurrent genetic abnormalities through molecular cytogenetics.

Purpose of the Study:

  • To summarize recent advances in multiple myeloma genetics.
  • Highlighting prognostic markers and novel therapeutic targets.

Main Methods:

  • Review of molecular cytogenetic techniques.
  • Analysis of genetic heterogeneity using expression array technologies.

Main Results:

  • Identification of several recurrent cytogenetic abnormalities.
  • These abnormalities serve as prognostic markers and potential therapeutic targets.

Conclusions:

  • Advances in genetic understanding offer potential for improved multiple myeloma patient treatment.
  • Further global analyses are expected to deepen insights into disease heterogeneity.

Related Experiment Videos